Will Prier, CFA, has extensive experience in equity research, currently serving as an Equity Research Analyst at Nuveen, a TIAA company, since October 2015, focusing on global pharmaceuticals, biotechnology, medical technology, healthcare services, and life science tools/diagnostics. Prior to this role, Will held positions as an Equity Research Associate at Nuveen, covering semiconductors and business services, and at Oppenheimer & Co. Inc., specializing in medical devices. Will began a career in equity research at Roth Capital Partners in June 2013. Will holds a Bachelor of Business Administration and a Bachelor of Arts in Finance and Economics from Concordia University-Irvine, graduating in 2013.
This person is not in any teams
This person is not in any offices